de completadas
de completadas
Retinoblastoma is a rare form of cancer that rapidly develops from the immature cells of a retina, the light-detecting tissue of the eye. It is the most common cancer of the eye in children, and it is almost exclusively found in young children.
It is caused by a genetic mutation in the retinoblastoma (RB1) gene and it can occur in one or both eyes. The most common and obvious sign of retinoblastoma is leukocoria. It can also cause vision problems such as crossed eyes, eye pain, vision loss, and red or irritated eyes. Treatment for retinoblastoma typically includes a combination of therapies such as laser therapy, cryotherapy, chemotherapy, and radiation therapy. Surgery to remove the affected eye (enucleation) may be necessary in some cases.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.